杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/08/27 | 1,874 | 1,888 | 1,853 | 1,854 | -11 | -0.6% | 105,100 |
| 2012/08/24 | 1,871 | 1,887 | 1,852 | 1,865 | +8 | +0.4% | 124,400 |
| 2012/08/23 | 1,850 | 1,864 | 1,836 | 1,857 | +15 | +0.8% | 108,000 |
| 2012/08/22 | 1,848 | 1,851 | 1,833 | 1,842 | +2 | +0.1% | 59,900 |
| 2012/08/21 | 1,843 | 1,850 | 1,829 | 1,840 | -3 | -0.2% | 134,800 |
| 2012/08/20 | 1,823 | 1,856 | 1,817 | 1,843 | +21 | +1.2% | 175,800 |
| 2012/08/17 | 1,825 | 1,828 | 1,797 | 1,822 | -1 | -0.1% | 148,600 |
| 2012/08/16 | 1,842 | 1,845 | 1,811 | 1,823 | -19 | -1% | 84,500 |
| 2012/08/15 | 1,859 | 1,859 | 1,828 | 1,842 | -17 | -0.9% | 85,500 |
| 2012/08/14 | 1,799 | 1,864 | 1,790 | 1,859 | +80 | +4.5% | 247,000 |
| 2012/08/13 | 1,758 | 1,785 | 1,757 | 1,779 | +12 | +0.7% | 92,000 |
| 2012/08/10 | 1,764 | 1,782 | 1,760 | 1,767 | -18 | -1% | 126,900 |
| 2012/08/09 | 1,760 | 1,785 | 1,737 | 1,785 | +11 | +0.6% | 227,700 |
| 2012/08/08 | 1,801 | 1,824 | 1,764 | 1,774 | -27 | -1.5% | 237,200 |
| 2012/08/07 | 1,825 | 1,825 | 1,798 | 1,801 | -45 | -2.4% | 292,800 |
| 2012/08/06 | 1,822 | 1,866 | 1,816 | 1,846 | +30 | +1.7% | 285,100 |
| 2012/08/03 | 1,771 | 1,836 | 1,739 | 1,816 | +68 | +3.9% | 392,600 |
| 2012/08/02 | 1,735 | 1,765 | 1,727 | 1,748 | +27 | +1.6% | 170,100 |
| 2012/08/01 | 1,709 | 1,730 | 1,702 | 1,721 | +12 | +0.7% | 115,400 |
| 2012/07/31 | 1,729 | 1,733 | 1,701 | 1,709 | -26 | -1.5% | 112,100 |
| 2012/07/30 | 1,700 | 1,735 | 1,686 | 1,735 | +31 | +1.8% | 132,800 |
| 2012/07/27 | 1,742 | 1,742 | 1,698 | 1,704 | -38 | -2.2% | 173,500 |
| 2012/07/26 | 1,737 | 1,744 | 1,715 | 1,742 | -2 | -0.1% | 132,700 |
| 2012/07/25 | 1,750 | 1,768 | 1,723 | 1,744 | +27 | +1.6% | 201,800 |
| 2012/07/24 | 1,693 | 1,732 | 1,693 | 1,717 | +34 | +2% | 206,400 |
| 2012/07/23 | 1,685 | 1,722 | 1,681 | 1,683 | -8 | -0.5% | 105,900 |
| 2012/07/20 | 1,721 | 1,750 | 1,690 | 1,691 | -64 | -3.6% | 226,100 |
| 2012/07/19 | 1,741 | 1,760 | 1,735 | 1,755 | +15 | +0.9% | 195,800 |
| 2012/07/18 | 1,737 | 1,761 | 1,735 | 1,740 | -6 | -0.3% | 132,500 |
| 2012/07/17 | 1,732 | 1,761 | 1,717 | 1,746 | +17 | +1% | 117,300 |
| 2012/07/13 | 1,728 | 1,751 | 1,713 | 1,729 | -4 | -0.2% | 97,700 |
| 2012/07/12 | 1,730 | 1,753 | 1,721 | 1,733 | +7 | +0.4% | 117,900 |
| 2012/07/11 | 1,745 | 1,745 | 1,715 | 1,726 | -21 | -1.2% | 86,500 |
| 2012/07/10 | 1,736 | 1,773 | 1,716 | 1,747 | +29 | +1.7% | 307,200 |
| 2012/07/09 | 1,730 | 1,730 | 1,704 | 1,718 | +12 | +0.7% | 190,800 |
| 2012/07/06 | 1,704 | 1,733 | 1,688 | 1,706 | -26 | -1.5% | 163,000 |
| 2012/07/05 | 1,750 | 1,757 | 1,712 | 1,732 | -7 | -0.4% | 150,200 |
| 2012/07/04 | 1,755 | 1,755 | 1,724 | 1,739 | +27 | +1.6% | 166,900 |
| 2012/07/03 | 1,675 | 1,714 | 1,672 | 1,712 | +56 | +3.4% | 186,100 |
| 2012/07/02 | 1,676 | 1,687 | 1,648 | 1,656 | -22 | -1.3% | 122,700 |
| 2012/06/29 | 1,632 | 1,692 | 1,632 | 1,678 | +46 | +2.8% | 90,000 |
| 2012/06/28 | 1,631 | 1,656 | 1,626 | 1,632 | -10 | -0.6% | 158,000 |
| 2012/06/27 | 1,633 | 1,642 | 1,625 | 1,642 | +10 | +0.6% | 35,000 |
| 2012/06/26 | 1,636 | 1,653 | 1,628 | 1,632 | -4 | -0.2% | 68,000 |
| 2012/06/25 | 1,654 | 1,655 | 1,626 | 1,636 | +16 | +1% | 175,000 |
| 2012/06/22 | 1,615 | 1,636 | 1,613 | 1,620 | +14 | +0.9% | 93,000 |
| 2012/06/21 | 1,610 | 1,617 | 1,592 | 1,606 | -4 | -0.2% | 174,000 |
| 2012/06/20 | 1,594 | 1,626 | 1,594 | 1,610 | +15 | +0.9% | 170,000 |
| 2012/06/19 | 1,572 | 1,606 | 1,572 | 1,595 | +12 | +0.8% | 125,000 |
| 2012/06/18 | 1,590 | 1,600 | 1,581 | 1,583 | -7 | -0.4% | 107,000 |
3101～
3150
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 146,400円 | +8.8% | +99.9% | 3.55% | 9.34倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ジーエヌアイ | 231,600円 | +21.7% | +999.9% | 0.00% | 9.64倍 | 3.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 持田薬 | 305,000円 | +3.0% | +27.5% | 2.62% | 19.31倍 | 0.83倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 栄研化 | 220,600円 | +0.4% | -8.4% | 2.40% | 28.32倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 87,800円 | +20.3% | - | 0.00% | 154.85倍 | 1.15倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
